• Exchange: New York
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

ZTS:US

34.8900 USD 0.1000 0.29%

As of 20:04:05 ET on 08/21/2014.

Snapshot for Zoetis Inc (ZTS)

Open: 34.7700 Day's Range: 34.6900 - 34.9800 Volume: 2,041,808
Previous Close: 34.7900 52wk Range: 28.1350 - 34.9800 1-Yr Rtn: +17.84%

Stock Chart for ZTS

No chart data available.
  • ZTS:US 34.8900
  • 1D
  • 1M
  • 1Y
34.7900
Interactive ZTS Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for ZTS

Current P/E Ratio (ttm) 24.5310
Estimated P/E(12/2014) 22.8637
Relative P/E vs. SPX 1.3757
Earnings Per Share (USD) (ttm) 1.4223
Est. EPS (USD) (12/2014) 1.5260
Est. PEG Ratio 1.9778
Market Cap (M USD) 17,486.64
Shares Outstanding (M) 501.19
30 Day Average Volume 2,823,155
Price/Book (mrq) 13.8740
Price/Sale (ttm) 3.7848
Dividend Indicated Gross Yield 0.83%
Cash Dividend (USD) 0.0720
Dividend Ex-Date 08/18/2014
5 Year Dividend Growth -
Next Earnings Announcement 11/05/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for ZTS

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for ZTS

Zoetis Inc discovers, develops, manufactures and commercializes animal health medicines and vaccines, with a focus on both livestock and companion animals. The Companies products are sold in North America, Europe, Africa, Asia, Australia and Latin America.

Juan Ramon AlaixChief Executive OfficerGlenn DavidActing CFO/Senior VP:Finance Ops
Kristin C PeckExec VP/Group PresidentRoxanne LaganoExec VP/Chief HR Officer
More Company Profile & Key Executives for ZTS

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil